Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amplify Cybersecurity ETF (HACK) vs Humana Inc (HUM) Price & Performance

Amplify Cybersecurity ETFTrade
Humana IncTrade

Price performance (Past 24H)

Key statistics

Amplify Cybersecurity ETF vs Humana Inc — how do they compare? Amplify Cybersecurity ETF trades at $130.76 (market cap $3.50B), while Humana Inc trades at $431.03 (market cap $46.49B). The key difference: Humana Inc is far larger — about 13.3× Amplify Cybersecurity ETF's market cap, and Humana Inc pays a 0.91% dividend while Amplify Cybersecurity ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Amplify Cybersecurity ETF for 28 Days and Humana Inc for 51 Days on average.

HACKHUM
Market Cap
$3.50B$46.49B
Volume
341,1762,567,704
Sector
Sector/ThematicHealth
52-Week High
$127.66$409.85
52-Week Low
$70.69$163.67
Typical Hold Time
28 Days51 Days
Enterprise Value
—$53.84B
Dividend Yield
—0.91%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amplify Cybersecurity ETF

HACK trades at $130.76, up 3.93% today and near its 52-week high, reflecting strong momentum amid bullish technical signals. The ETF benefits from rising cybersecurity demand driven by AI safety concerns and recent earnings beats from holdings like CrowdStrike. Technical indicators show a bullish trend with support at $124 and resistance at $126, while short interest has surged, indicating mixed sentiment.

Outlook remains positive due to sector tailwinds from AI-driven cyber threats, but risks include high valuation sensitivity and increased short interest. The ETF's diversified exposure to cybersecurity leaders offers growth potential, though investor caution is warranted given its proximity to record highs and competitive pressures.

Humana Inc

Humana (HUM) trades at $387.12, down 2.37% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $457.05 implying 18% upside. Revenue growth is robust, reaching $129.7 billion in 2025, though net income margin has compressed to 0.88%. Recent news includes a Barclays upgrade to a $515 target and upcoming Q3 earnings on November 6, 2026.

The stock offers potential from strong revenue expansion and positive analyst sentiment, but faces risks from margin pressure and regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes. The outlook hinges on earnings performance and Medicare Advantage plan changes affecting membership.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HACK
100% Buy0% Sell
Avg holding period · 28 Days
HUM
93% Buy7% Sell
Avg holding period · 51 Days

Top news

Latest headlines on both assets

About Amplify Cybersecurity ETF

HACK provides diversified exposure to the global cybersecurity industry. It invests across the full value chain, including hardware, software, and consulting services, with key holdings in firms like Broadcom, Cisco, and Palo Alto Networks.

Read more on HACK →

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM →